Christopher H. Goss

15.9k total citations · 4 hit papers
236 papers, 10.4k citations indexed

About

Christopher H. Goss is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Surgery. According to data from OpenAlex, Christopher H. Goss has authored 236 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 195 papers in Pulmonary and Respiratory Medicine, 54 papers in Epidemiology and 39 papers in Surgery. Recurrent topics in Christopher H. Goss's work include Cystic Fibrosis Research Advances (177 papers), Tracheal and airway disorders (56 papers) and Neonatal Respiratory Health Research (37 papers). Christopher H. Goss is often cited by papers focused on Cystic Fibrosis Research Advances (177 papers), Tracheal and airway disorders (56 papers) and Neonatal Respiratory Health Research (37 papers). Christopher H. Goss collaborates with scholars based in United States, Canada and United Kingdom. Christopher H. Goss's co-authors include Moira L. Aitken, Bruce C. Marshall, Margaret Rosenfeld, Gordon D. Rubenfeld, Jane L. Burns, Don B. Sanders, Patrick A. Flume, Nicole Mayer-Hamblett, Bradley S. Quon and Peter J. Mogayzel and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Christopher H. Goss

229 papers receiving 10.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cystic Fibrosis Pulmonary Guidelines

2007 765 citations Patrick A. Flume, Christopher H. Goss et al. American Journal of Respiratory and Critical Care Medicine profile →
Cystic Fibrosis Pulmonary Guidelines: Treatment of Pulmonary Exacerbations

2009 522 citations Patrick A. Flume, Christopher H. Goss et al. American Journal of Respiratory and Critical Care Medicine profile →
Cystic fibrosis

2015 369 citations Christopher H. Goss et al. profile →
The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry

2016 324 citations Aliza K. Fink, Christopher H. Goss et al. profile →

Peers

Countries citing papers authored by Christopher H. Goss

Since Specialization

Citations

This map shows the geographic impact of Christopher H. Goss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher H. Goss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher H. Goss more than expected).

Fields of papers citing papers by Christopher H. Goss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher H. Goss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher H. Goss. The network helps show where Christopher H. Goss may publish in the future.

Co-authorship network of co-authors of Christopher H. Goss

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher H. Goss. A scholar is included among the top collaborators of Christopher H. Goss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher H. Goss. Christopher H. Goss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Attitudes toward and preparedness for lung transplantation among individuals with cystic fibrosis in the era of highly effective modulators 2024 ·BMC Pulmonary Medicine ·(unknown), Siddhartha G. Kapnadak, (unknown), Oliver J. McElvaney, (unknown), (unknown), (unknown), (unknown), Jordan Dunitz, Joanne Billings, Joseph M. Pilewski, Milene T. Saavedra, Christopher H. Goss, Andrea L. Hartzler, Kathleen J. Ramos	2
2	Wellness in the modulator era: An observational study of the impact of CFTR modulator therapy on the well-being of people with cystic fibrosis 2024 ·Journal of Cystic Fibrosis ·Aricca D. Van Citters, (unknown), Jessica A. Alvarez, Cynthia D. Brown, (unknown), (unknown), (unknown), Anna M. Georgiopoulos, Christopher H. Goss, Traci M. Kazmerski, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	9
3	Impact of sinus surgery in people with cystic fibrosis and chronic rhinosinusitis in the era of highly effective modulator therapy: Protocol for a prospective observational study 2024 ·PLoS ONE ·Christine Liu, (unknown), Jeremiah A. Alt, Todd Bodner, Naweed I. Chowdhury, Anne E. Getz, Peter H. Hwang, Adam J. Kimple, Jess C. Mace, Timothy L. Smith, Zachary M. Soler, Christopher H. Goss, Jennifer L. Taylor‐Cousar, Milene T. Saavedra, Daniel M. Beswick	0
4	Remote endpoints for clinical trials in cystic fibrosis: Report from the U.S. CF foundation remote endpoints task force 2024 ·Journal of Cystic Fibrosis ·Jordana E. Hoppe, J Sjöberg, Gina Hong, Katie R. Poch, Edith T. Zemanick, Stephanie Thee, C. Edmondson, Dhiren Patel, Meghana Sathe, Drucy Borowitz, Melissa S. Putman, Noah Lechtzin, Kristin A. Riekert, (unknown), Christopher H. Goss, (unknown), Margaret Rosenfeld	3
5	Impact of day-to-day variation in FEV1 on measures of change: A conceptual description 2024 ·Journal of Cystic Fibrosis ·Amalia Magaret, (unknown), Lindsay J. Caverly, Elizabeth A. Cromwell, (unknown), Margaret Rosenfeld, Christina S. Thornton, Christopher H. Goss	2
6	727 Longitudinal analysis of respiratory symptoms in people with cystic fibrosis with advanced lung disease on and off ETI 2023 ·Journal of Cystic Fibrosis ·(unknown), (unknown), (unknown), Joseph M. Pilewski, Jordan Dunitz, Christopher H. Goss, Kathleen J. Ramos	1
7	Metabolism and pharmacokinetics of vitamin D in patients with cystic fibrosis 2023 ·The Journal of Steroid Biochemistry and Molecular Biology ·(unknown), Simon Hsu, Moira L. Aitken, Christopher H. Goss, Andrew N. Hoofnagle, Leila R. Zelnick, (unknown), Cora M. Best, Kenneth E. Thummel, Bryan Kestenbaum, Ian H. de Boer, Yvonne S. Lin	4
8	Olfactory loss in people with cystic fibrosis: Community perceptions and impact 2023 ·Journal of Cystic Fibrosis ·Jessa E. Miller, Christine Liu, Edith T. Zemanick, Jason C. Woods, Christopher H. Goss, Jennifer L. Taylor‐Cousar, Daniel M. Beswick	2
9	Role of hyperglycemia in cystic fibrosis pulmonary exacerbations 2023 ·Journal of Cystic Fibrosis ·(unknown), Aniket Sidhaye, Phuong T. Vu, Sonya L. Heltshe, Christopher H. Goss, Patrick A. Flume, Andrea Kelly, Margaret Rosenfeld	1
10	The lung allocation score and other available models lack predictive accuracy for post-lung transplant survival 2022 ·The Journal of Heart and Lung Transplantation ·(unknown), (unknown), Christopher H. Goss, Erika D. Lease, Christian A. Merlo, Siddhartha G. Kapnadak, Kathleen J. Ramos	11
11	Use of elexacaftor/tezacaftor/ivacaftor among cystic fibrosis lung transplant recipients 2022 ·Journal of Cystic Fibrosis ·Kathleen J. Ramos, Jennifer S. Guimbellot, Maryam Valapour, (unknown), (unknown), Christopher H. Goss, Joseph M. Pilewski, Albert Faro, Joshua M. Diamond	30
12	Contemporary cystic fibrosis incidence rates in Canada and the United States 2022 ·Journal of Cystic Fibrosis ·Anne L. Stephenson, (unknown), Jenna Sykes, Sanja Stanojevic, (unknown), Bradley S. Quon, Albert Faro, Bruce C. Marshall, Kathleen J. Ramos, Josh Ostrenga, (unknown), (unknown), Elizabeth A. Cromwell, Christopher H. Goss	18
13	The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network 2020 ·Journal of Cystic Fibrosis ·(unknown), Nicole Mayer-Hamblett, Christopher H. Goss, George Retsch‐Bogart, Jill M. VanDalfsen, (unknown), Daniel Rosenbluth, John Clancy, Amy J. Hoffman, David P. Nichols	7
14	Improving the Affordability of Prescription Medications for People with Chronic Respiratory Disease: An Official American Thoracic Society Policy Statement 2018 ·American Journal of Respiratory and Critical Care Medicine ·Minal Patel, Valerie G. Press, Lynn B. Gerald, (unknown), (unknown), Lee K. Brown, Richard W. Costello, Courtney Crim, Mark Forshag, Andrea S. Gershon, Christopher H. Goss, MeiLan K. Han, Todd A. Lee, Stuart C. Sweet, Joe K. Gerald	33
15	Data that empower: The success and promise of CF patient registries 2017 ·Pediatric Pulmonology ·Aliza K. Fink, Deena R. Loeffler, Bruce C. Marshall, Christopher H. Goss, Wayne J. Morgan	21
16	A standardized approach to estimating survival statistics for population-based cystic fibrosis registry cohorts 2015 ·Journal of Clinical Epidemiology ·Jenna Sykes, Sanja Stanojevic, Christopher H. Goss, Bradley S. Quon, Bruce C. Marshall, Kristofer Petren, Josh Ostrenga, Aliza K. Fink, Alexander Elbert, Anne L. Stephenson	30
17	Alveolar Macrophage Secretory Products Augment the Response of Rat Pulmonary Artery Endothelial Cells to Hypoxia and Reoxygenation 2008 ·The Annals of Thoracic Surgery ·(unknown), (unknown), Alexander S. Farivar, Christopher H. Goss, Michael S. Mulligan	16
18	Disease-specific Reference Equations for Lung Function in Patients with Cystic Fibrosis 2005 ·American Journal of Respiratory and Critical Care Medicine ·Michal Kulich, Margaret Rosenfeld, Jonathan D. Campbell, Richard Kronmal, Ron Gibson, Christopher H. Goss, Bonnie W. Ramsey	50
19	Effect of Ambient Air Pollution on Pulmonary Exacerbations and Lung Function in Cystic Fibrosis 2004 ·American Journal of Respiratory and Critical Care Medicine ·Christopher H. Goss, (unknown), Jonathan S. Schildcrout, Lianne Sheppard, Joel D. Kaufman	194
20	Use of fast atom bombardment mass spectrometry (FAB MS) for the analysis of zinc stable isotopes in biological samples 1986 ·Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) ·(unknown), Paul V. Fennessey, Michael Hambidge, L. Miller, Christopher H. Goss	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact